ICN To Acquire Roche Benzodiazepines Flurazepam And Nitrazepam
Executive Summary
ICN will acquire Roche benzodiazepines flurazepam and nitrazepam in an agreement that also involves the gastrointestinal therapy Librax and the oncologic agent fluorouracil, Roche announced Oct. 5.